Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03967743 · ClinicalTrials.gov registry record
Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders
A clinical trial of Genetic Disease and Genetic Predisposition to Disease, sponsored by Boston Children's Hospital.
- Recruiting
- Registry status
- 150
- Enrollment target
- 1
- Study location
NCT03967743 is a study of Genetic Disease and Genetic Predisposition to Disease that is actively recruiting participants, run by Boston Children's Hospital. The registered enrollment target is 150 participants, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03967743, a study of Genetic Disease and Genetic Predisposition to Disease, is actively recruiting participants, sponsored by Boston Children's Hospital.
- RECRUITING
- Registry status
- 150 participants
- Enrollment target
- 1
- Study location
Study Summary
The main objective of this study is to apply a well-established model of developmental surveillance (which evolved to characterize the outcomes of very low birth weight infants) to infants with genetic disorders. A novel clinical model for infants with rare genetic disorders has been created as a joint initiative between the Division of Newborn Medicine's NICU Growth and Developmental Support Programs (NICU GraDS) program and the Division of Genetics at Boston Children's Hospital (BCH). This study plans to enroll patients with genetic syndromes seen in this clinic into a prospective, longitudinal study in order to characterize their developmental profiles and needs.
Conditions Studied
Study Locations (1)
Massachusetts
- Boston Children's Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2019-08-26 |
| Est. Completion | 2025-12-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03967743
The ClinicalTrials.gov registry entry for NCT03967743 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,556-participant average among 30 other Genetic Disease trials with a reported enrollment target (94% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.
The record links to 5 conditions, with Genetic Disease appearing as the primary indexed condition, and to 0 interventions.
NCT03967743 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03967743 about?
NCT03967743 is a clinical study titled "Application of a Systematic Developmental Assessment to a Novel Population: Infants With Rare Genetic Disorders". The main objective of this study is to apply a well-established model of developmental surveillance (which evolved to characterize the outcomes of very low birth weight infants) to infants with genetic disorders. A novel clinical model for infants with rare genetic disorders has been created as a jo...
What is the current status of trial NCT03967743?
This trial is currently recruiting. The enrollment target is 150 participants. The study started on 2019-08-26. Estimated completion is 2025-12-01.
What conditions does trial NCT03967743 study?
This clinical trial studies the following conditions: Genetic Disease, Genetic Predisposition to Disease, Development, Child, Development, Infant, Genetic Syndrome.
Who is sponsoring clinical trial NCT03967743?
This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03967743 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Genetic Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
An Adaptive Clinical Trial of BeginNGS Newborn Screening for Hundreds of Genetic Diseases by Genome Sequencing
RECRUITING · NA
-
Delineating the Molecular Spectrum and the Clinical, Imaging and Neuronal Phenotype of Chopra-Amiel-Gordon Syndrome
RECRUITING
-
Rett Syndrome Registry
RECRUITING
-
Natural History Study of Patients with HPDL Mutations
RECRUITING
-
Diagnostic Odyssey: Whole Genome Sequencing (WGS)
RECRUITING
-
Clinical and Genetic Evaluation of Individuals With Undiagnosed Disorders Through the Undiagnosed Diseases Network
RECRUITING
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.